“Adjuvant Therapy With Nivolumab Versus Placebo in Patients With Resected Stage IIB C Melanoma (CheckMate 76K)”. SKIN The Journal of Cutaneous Medicine, vol. 7, no. 2, Mar. 2023, p. s163, https://doi.org/10.25251/skin.7.supp.163.